Neurocrine Biosciences
NBIX
#1521
Rank
NZ$19.81 B
Marketcap
$198.75
Share price
-0.39%
Change (1 day)
-13.59%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): NZ$0.85 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are NZ$2.35 Billion. , an increase over its 2023 earnings that were of NZ$0.54 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.89 B64.57%
2023 NZ$0.54 B41.13%
2022 NZ$0.38 B73.74%
2021 NZ$0.22 B-8.82%
2020 NZ$0.24 B77.78%
2019 NZ$0.13 B49.83%
2018 NZ$91.3 M-142.57%
2017 -NZ$0.22 Billion-14.73%
2016 -NZ$0.26 Billion53.15%
2015 -NZ$0.17 Billion46.25%
2014 -NZ$0.12 Billion29.66%
2013 -NZ$86.61 Million-3530.8%
2012 NZ$2.52 M-95.73%
2011 NZ$59.13 M
2009 -NZ$83.14 Million-45.38%
2008 -NZ$0.16 Billion-58.87%
2007 -NZ$0.38 Billion87.3%
2006 -NZ$0.2 Billion351.97%
2005 -NZ$43.72 Million-52.09%
2004 -NZ$91.24 Million-10.98%
2003 -NZ$0.11 Billion
2001 -NZ$76.51 Million
1999 -NZ$34.51 Million108.32%
1998 -NZ$16.57 Million
1996 NZ$5.05 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$33.51 M-96.26%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.71 B 203.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
-NZ$46.97 Million-105.25%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.10 B 2,370.37%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.47 B 623.94%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.37 B 2,065.01%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$38.73 Million-104.33%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$72.81 Million-108.14%๐Ÿ‡บ๐Ÿ‡ธ USA